IL-6 and IL-8 as part of the host response [5] . The uroepithelial cells lining the human urinary tract express the adenosine A 1 , A 2A and A 2B receptor subtypes [6, 7] but the role of these receptors in the mucosal inflammatory network is not understood. In other tissues, signaling via adenosine A 2A receptors inhibits inflammation [8] , in part by decreasing the release of proinflammatory cytokines [9, 10] . The anti-inflammatory characteristics of adenosine A 2B receptors also involve inhibition of cytokine production [4] . Most of the anti-inflammatory effects of adenosine are thought to involve a rise in intracellular cAMP levels [11] . Generally, activation of the adenosine A 1 and A 3 receptors leads to a decrease in intracellular cAMP levels by coupling to inhibitory G i/o proteins. In contrast, adenosine A 2A and A 2B receptors couple to stimulatory G s proteins and activate adenylyl cyclase, production of cAMP and activation of the PKA/ CREB pathway [12] . In addition, by coupling to G q proteins the adenosine A 2B receptor is able to activate phospholipase C [13] . All the adenosine receptors have also been shown to activate at least one subgroup of the mitogen-activated protein kinase (MAPK)-family, including ERK 1/2, p38 and JNK [14] .
The aim of this study was to examine adenosine A 2A and A 2B receptor expression and signaling pathways evoked by these receptors in human uroepithelial cells. Besides cAMP, other signaling pathways implicated in inflammation, such as MAPK signaling, JAK-STAT signaling and NF-B signaling, were also studied. In addition, we examined whether adenosine A 2A and A 2B receptor activation had an anti-or proinflammatory profile on the host IL-8 response.
Materials and Methods

Urinary Tract Epithelial Cells and Bacteria
The human urinary tract epithelial cell line UROtsa was kindly supplied by Prof. Scott Garrett (University of North Dakota, USA). The UROtsa cell line is derived from epithelial cells lining the ureter and immortalized by using SV-40 large T antigen [15] . UROtsa cells were cultured in DMEM supplemented with 10% fetal bovine serum, 2 mmol/l L -glutamine, 1 mmol/l sodium pyruvate, 1 mmol/l non-essential amino acids, 100 U/ml penicillin and 100 g/ml streptomycin (all from Sigma Aldrich, St. Louis, Mo., USA) at 37 ° C, 5% CO 2 in a humidified atmosphere and subcultured when confluent.
The uropathogenic Escherichia coli (UPEC) strain IA2, which was originally isolated from a patient with acute pyelonephritis, expresses both P and type 1 fimbriae. IA2 was cultured on tryptic soy agar plates (Becton, Dickinson, Sparks, Md., USA) at 37 ° C.
Cell Stimulation Procedure
For bacterial infection, confluent monolayers of UROtsa cells were incubated with cell culture medium containing 10 8 CFU/ml of UPEC strain IA2. Bacterial multiplication was limited by incubating the cells with gentamycin (50 g/ml) 24 h prior to infection. Gentamycin was excluded during infections. Cells incubated with medium alone were used as control.
RNA Preparation, cDNA Synthesis and Reverse Transcription-Polymerase Chain Reaction
Total RNA was isolated from UROtsa cells using RNeasy Minikit (Qiagen, Valencia, Calif., USA) according to the manufacturer's instructions; 1 g of total RNA was converted to cDNA using oligo-dT 16 primers (1 mol/l; Applied Biosystems, Foster City, Calif., USA) and the Omniscript RT kit (Qiagen). RNA was controlled for genomic DNA contamination. PCR (25 l reaction volume) was performed using Ready-To-Go PCR beads (Amersham Biosciences, Little Chalfont, UK). A volume of 2-5 l of the RT reaction was mixed with primers (0.5 mol/l) for A 1 : forward 5 -CTA CCT AAT CCG CAA GCA GC-3 and reverse 5 -GTC ATC AGG CCT CTC TTC TGG-3 (367 bp), A 2A : forward 5 -AAC CTG CAG AAC GTC ACC A-3 and reverse 5 -GTC ACC AAG CCA TTG TAC CG-3 (245 bp), A 2B : forward 5 -GTG CCA CCA ACA ACT GCA CAG AAC-3 and reverse 5 -CTG ACC ATT CCC ACT CTT GAC ATC-3 (517 bp), A 3 : forward 5 -CAC CAC CTT CTA TTT CAT TGT CTC T-3 and reverse 5 -GGT ACT CTG AGG TCA GTT TCA TGT T-3 (337 bp) or glyceraldehyde-3-phosphate dehydrogenase: forward 5 -ATT CCA TGG CAC CGT CAA GGCT-3 and reverse 5 -TCA GGT CCA CCA CTG ACA CGT T-3 (571 bp) and PCR was performed in a thermal cycler (Perkin Elmer GeneAmp PCR system). PCR was run with an initial denaturation for 1 min at 94 ° C followed by 35 cycles at 94 ° C for 1 min, 65 ° C for 30 s and 1 min at 72 ° C, followed by a final extension step at 72 ° C for 10 min for the adenosine A 1 and A 2A receptors. For A 2B and A 3 receptors, initial denaturation was run for 4 min at 94 ° C followed by 35 cycles at 94 ° C for 45 s, 60 ° C for 45 s and 2 min at 72 ° C and a final extension step at 72 ° C for 7 min. PCR products were analyzed by agarose gel (2%) electrophoresis and visualized by ethidium bromide staining.
Western Blot Analysis
UROtsa cells were harvested in 0.01 mol/l TBS supplemented with the protease inhibitor cocktail Complete mini (Roche Diagnostics, Pleasanton, Calif., USA) using a cell scraper. The lysate was homogenized with a syringe and 20-gauge needle followed by sonication. The bicinchoninic acid (BCA-1) kit (Pierce, Rockford, Ill., USA) was used to determine the protein content of the samples. Twenty micrograms of protein were mixed with Tris-glycine SDS sample buffer (Invitrogen, Carlsbad, Calif., USA), subjected to 10% Tris-glycine SDS gel electrophoresis (Invitrogen) and transferred to Hybond TM -P PVDF membrane (Amersham Biosciences). Unspecific sites were blocked by incubating the membrane in 5% non-fat milk for 1 h. Detection of A 2A and A 2B receptor protein was performed using a mouse monoclonal antibody against human A 2A receptors and a rabbit polyclonal antibody against human A 2B receptors, diluted 1: 500 overnight (both from Santa Cruz Biotechnology, Santa Cruz, Calif., USA). The membrane was then incubated for 1 h with HRP-linked goat anti-mouse IgG (Pierce; 1: 20,000) or goat anti-rabbit IgG (Dako, Glostrup, Denmark; 1: 10,000). Blots were developed by enhanced chemilumi-nescence Western blotting detection reagent ECL + and exposed to Hyperfilm ECL (both from Amersham Biosciences).
Determination of Intracellular cAMP
Confluent UROtsa cells in 24-well plates were stimulated with the adenosine A 2 receptor agonist CPCA (0.1, 1 and 10 mol/l), the adenosine A 2A receptor agonist CGS 21680 (0.1 and 1 mol/l) or the adenylyl cyclase activator forskolin (10 mol/l) for 20 min. In some experiments, UROtsa cells were exposed to IA2 for 1 h. The medium was then removed and cells were lysed with 0.1 mol/l HCl for 20 min at room temperature, collected by scraping and centrifuged at 600 g for 10 min. The supernatant was collected, acetylated and used for measuring cAMP with the direct cyclic AMP Correlate-EIA TM kit (Assay Designs, Ann Arbor, Mich., USA). Optical density was measured at 405 nm in a Spectracount TM Packard AS 10001 fluorescence spectrophotometer.
Determination of Intracellular Phosphoproteins by Luminex
UROtsa cells were seeded in 24-well plates, and when confluent normal medium was replaced with serum-free medium and cells were incubated for 4 h. Thereafter UROtsa cells were stimulated with the adenosine A 2 receptor agonist CPCA (1 and 10 mol/l) and the adenosine A 2A receptor agonist CGS 21680 (0.1 and 1 mol/l) for 7 or 15 min. Cells stimulated with EGF (50 ng/ ml) were used as positive controls. Cells were lysed with lysis buffer (provided by the Luminex kit) supplemented with Complete Mini, a protease inhibitor cocktail (Roche Diagnostics, Pleasanton, Calif., USA) on an orbital shaker. The lysate was filtered in Spin-X centrifugation tubes (0.22-m filter; Sigma) at 14,000 g for 1 min and then stored at -70 ° C until analysis. Unstimulated cells were used as control. The protein concentrations of the samples were determined with the BCA TM protein assay kit (Pierce). Equal amounts of protein (5 g) were analyzed for ERK 1/2, CREB, STAT3, STAT5, JNK, p70S6 kinase, p38 and I B ␣ with the Milliplex TM MAP 8-plex multi-pathway signaling kit (Millipore, Billerica, Mass., USA) according to manufacturer's instructions on a Luminex 200 TM (Millipore). Data are expressed as mean fluorescence intensity.
Determination of IL-8 Secretion
Confluent UROtsa cells grown in 24-well plates were exposed to 10 6 , 10 7 and 10 8 CFU/ml of UPEC strain IA2 for 6 and 24 h or forskolin (10 mol/l) for 24 h. To determine the effect of adenosine A 2 receptor activation, UROtsa cells were exposed to IA2 (10 8 CFU/ml) and after 2 h of infection, cells were stimulated with the adenosine A 2A receptor agonist CGS 21680 (0.1 and 1 mol/l; Sigma) or the adenosine A 2 receptor agonist CPCA (1 and 10 mol/l) for an additional 22 h. In some experiments cells were treated with the adenosine A 2A receptor antagonist SCH 58261 (10 nmol/l ; Sigma) 20 min prior to the addition of CPCA. Supernatants were centrifuged at 5,000 g for 7 min. Samples were placed at -20 ° C until IL-8 was analyzed with the BD OptEIA TM human IL-8 ELI-SA kit II (BD Biosciences Pharmingen, San Diego, Calif., USA). IL-8 was determined by measuring optical density at 450 nm in a Spectracount TM Packard AS 10001 fluorescence spectrophotometer.
Statistical Analysis
Data are shown as means 8 SEM and n indicates the number of independent experiments. Student's unpaired t test or ANOVA, followed by Dunnett's post hoc test, was used with statistical significance considered at p ! 0.05.
Results
Adenosine Receptor Expression
RT-PCR analysis was used to examine the expression of adenosine receptor mRNA in UROtsa cells. UROtsa cells showed mRNA expression for the adenosine A 1 , A 2A and A 2B receptor subtypes, but transcript for the adenosine A 3 receptor could not be detected ( fig. 1 a) fig. 1 b) .
Effect of Adenosine A 2 Receptor Activation on cAMP Accumulation
The effects of the adenosine A 2 receptor agonist CPCA and the selective adenosine A 2A receptor agonist CGS 21680 on cAMP accumulation was investigated in UROtsa cells ( fig. 2 a) . CPCA significantly increased cAMP levels at both 1 (p ! 0.05) and 10 mol/l (p ! 0.001). No significant changes in cAMP accumulation were found in response to CGS 21680 (0.1 and 1 mol/l). Forskolin (10 mol/l), a known activator of adenylyl cyclase, increased cAMP accumulation to approximately the same level as CPCA (10 mol/l; fig. 2 a) . The intracellular cAMP levels in UROtsa cells infected with UPEC strain IA2 for 1 h were slightly, although not significantly, higher than in non-stimulated control cells ( fig. 2 b) .
Effect of Adenosine A 2 Receptor Activation on Intracellular Phosphoproteins
To further investigate intracellular pathways involved in adenosine A 2 receptor activation in UROtsa cells we studied changes in phosphorylated proteins by a multiplex immunoassay. This assay simultaneously measures changes in 8 phosphorylated proteins in the same sample. For validation, lysates of heat shock-treated/arsenite-, TNF ␣ -and EGF-stimulated HeLa cells were used as positive controls. Stimulation of UROtsa cells with EGF (50 ng/ml), known to activate many of the pathways included in the immunoassay, was used as an internal positive control. The response of the different phosphoproteins to EGF is shown in figure 3 a. A strong induction of CREB was seen in CPCA-stimulated cells. After stimulation with CPCA 1 and 10 mol/l for 7 min, CREB increased ϳ 10-fold (p ! 0.01) and ϳ 14 fold (p ! 0.001), respectively, compared to non-stimulated control. The CPCA-induced increase in CREB after 15 min was ϳ 16-and 19-fold (p ! 0.001) with 1 and 10 mol/l, respectively ( fig. 3 b) . The adenosine A 2A agonist CGS 21680 (0.1 and 1 mol/l) induced a small but significant (p ! 0.05) increase in CREB after 15 min ( fig. 3 c) . A significant decrease in ERK 1/2 (p ! 0.01; fig. 3 d) and STAT3 (p ! 0.05; fig. 3 e) was observed in response to 1 mol/l CGS 21680. By contrast, CPCA did not change ERK 1/2 or STAT3 ( fig. 3 d, e) . Phosphorylation of JNK, p38, STAT5, p70S6 kinase and I B ␣ was not significantly affected by CGS 21680 or CPCA (data not shown).
Effect of Adenosine A 2 Receptor Activation on IL-8 Secretion
Time-course experiments with different bacterial concentrations (10 6 , 10 7 and 10 8 CFU/ml at 6 and 24 h) were first performed to obtain optimal conditions for studies of UPEC-evoked IL-8 production. A minor increase in IL-8 production was seen with 10 8 CFU/ml after 6 h, but the strongest IL-8 response was found after 24 h of infection with 10 8 CFU/ml ( fig. 4 a) . Stimulation of cells with IA2 (10 8 CFU/ml) for 24 h was therefore chosen to study the effect of adenosine A 2 receptor activation on IL-8 secretion after UPEC infection. The adenosine A 2A receptor agonist CGS 21680 (0.1 and 1 mol/l) had no effect on basal or UPEC-evoked IL-8 production ( fig. 4 b) . The adenosine A 2 receptor agonist CPCA (1 and 10 mol/l) or the 'adenosine A 2B receptor agonist combination' CPCA + the adenosine A 2A receptor antagonist SCH 58261 (10 nmol/l) did not affect basal or UPEC-evoked IL-8 production ( fig. 4 c) . Forskolin (10 mol/l) significantly increased IL-8 production by 24 8 5% (n = 5; p ! 0.05; fig. 4 
d).
Discussion
In the present study, a basal mRNA expression of the adenosine A 1 , A 2A and A 2B , but not A 3 , receptor subtypes was shown in the human uroepithelial cell line UROtsa. This is in line with previous studies conducted on T24 human bladder carcinoma cells [7] and A498 human kidney carcinoma cells [6] . Western blot analysis confirmed a high expression of the adenosine A 2B receptor and a lower expression of the A 2A receptor subtype.
Both high-affinity adenosine A 2A and low-affinity adenosine A 2B receptors are coupled to stimulatory G s proteins which lead to the production of cAMP [12] . However, in our study the selective adenosine A 2A receptor agonist CGS 21680 failed to stimulate cAMP production in UROtsa cells. In agreement with our data, Phelps et al. [7] did neither detect cAMP elevation upon adenosine A 2A receptor activation in T24 bladder cells and nor any increase in intracellular Ca 2+ . These data may suggest that the adenosine A 2A receptor in human uroepithelial cells is functionally inactive or that cAMP-and Ca 2+ -independent signaling pathways are used for activation. Calcium-and cAMP-independent signaling have been described for adenosine A 2A receptors in PC12 cells, where a Ca 2+ -independent isoform of PKC phosphorylates and inhibits adenylyl cyclase isozymes and cAMP signaling [16] .
Due to the lack of specific adenosine A 2B receptor agonists we used the general adenosine A 2 receptor agonist CPCA to stimulate adenosine A 2B receptors. Since the adenosine A 2A response was modest CPCA may be considered as an adenosine A 2B receptor agonist in this study. CPCA caused a strong cAMP response similar to that of the adenylyl cyclase activator forskolin. It has recently been shown that UPEC stimulate a rise in cAMP in the human bladder epithelial cell line 5637 [17, 18] . In our study, a minor, although nonsignificant, rise in cAMP levels was observed in UPEC-infected UROtsa cells.
To investigate pathways other than cAMP that could be involved in adenosine A 2 receptor activation in UROtsa cells, we studied changes in several phosphorylated signaling proteins. In agreement with the cAMP assay, CPCA induced a strong phosphorylation of the cAMPresponsive elements binding protein CREB. In addition, CGS 21680 induced a small but significant increase in phosphorylated CREB. These data may suggest that adenosine A 2A receptor activation, after all, stimulates cAMP but below the detection limit of the cAMP assay. Furthermore, we found a significant decrease in STAT3, a downstream target of many inflammatory cytokines such as IL-6 [19] and the MAPK ERK 1/2 by CGS 21680 but not CPCA stimulation. It is generally believed that inhibition of proinflammatory mediators by adenosine A 2A receptor activation is mediated through increased cAMP-CREB activation and subsequently inhibition of NF-B activity [20, 21] . The key event in NF-B activation is I B ␣ phosphorylation [22] . However, CGS 21680 and CPCA had no significant effects on I B ␣ phosphorylation, at least not at the stimulation times used in our study. Taken together, a marked difference was observed between adenosine A 2A and A 2B receptor signaling in uroepithelial cells. A cAMP-CREB signaling pathway was found for the adenosine A 2B receptor, while adenosine A 2A receptor activation inhibited STAT3 and ERK 1/2 signaling but failed to activate cAMP.
The anti-inflammatory characteristics of adenosine A 2 receptors involve inhibition of cytokine production [4, 9, 10] . While the adenosine A 2A receptor subtype is well established as anti-inflammatory there are some controversies whether the adenosine A 2B receptor subtype is pro-or anti-inflammatory [4] . Studies in adenosine A 2B knockout mice have suggested that activation of adeno sine A 2B receptors on certain cells, particularly macrophages, inhibits inflammation [23] while another study favors a proinflammatory profile for this receptor [24] . Because the proinflammatory cytokine IL-8 is essential for neutrophil transmigration across the infected urothelium [5] , we examined the possible regulatory effect of adenosine A 2 receptors on IL-8 production. The results demonstrated that adenosine A 2A and A 2B receptor activation did not affect basal or UPEC-induced IL-8 release. Activation of adenylyl cyclase by forskolin and adenosine A 2B receptors by CPCA increase cAMP levels to approximately the same extent but both had modest effects on IL-8 secretion. A minor increase in cAMP was seen in UPEC-infected cells while the production of IL-8 was prominent. Therefore, UPEC-evoked IL-8 production seems to be mediated by pathways other than from cAMP signaling, such as the NF-B pathway. A recent study provided evidence that UPEC-evoked IL-6 release in the human bladder epithelial cell line 5637 involved not only the classical NF-B pathway but also a cAMP-CREB pathway [25] . The cAMP pathway resulted in an early IL-6 response but the amount of IL-6 generated by this pathway was less than for the NF-B-associated pathway.
It has previously been found that the UPEC-evoked IL-6 response required NF B and p38 MAPK activation in T24 bladder carcinoma cells [26] and serine/threonine kinases in A498 kidney cells [27] . The induction of IL-8 by type 1 fimbriated UPEC involves the MAPK-family (p38, JNK and ERK) and activator protein-1 (AP-1) [28] . Phosphorylation of p38 is required for P-fimbriated UPEC activation of both AP-1 and NF-B and the subse-quent induction of IL-8 [28] . The UPEC strain used in this study expresses both type 1 and P fimbriae, and our preliminary data demonstrate up-regulation of p38, JNK, ERK 1/2 and I B ␣ in UPEC-infected UROtsa cells [unpubl. observations]. Our data suggest that adenosine A 2A receptor activation inhibits some of the signaling pathways that are induced in host urinary tract epithelial cells by UPEC infection. However, this adenosine A 2A receptor activation did not functionally suppress UPEC-evoked IL-8 production in UROtsa cells. Stimulation of adenosine A 2A receptors with CGS 21680 decreased TNF-␣ and macrophage inflammatory peptides, but not IL-8, in lipopolysaccharide-stimulated human neutrophils [29] . Thus, it is possible that an anti-inflammatory profile of the adenosine A 2A receptor had been noted if other markers for inflammation than IL-8 had been evaluated. It is well accepted that adenosine A 2A receptor activation inhibits proinflammatory mediators in immune cells [8] , while immunomodulatory consequences of adenosine A 2A receptor activation in non-immune cells like epithelial cells require further studies. We have previously shown that adenosine A 2A receptor activation reduces UPEC-evoked IL-6 production in a kidney epithelial cell line [6] , while a study performed on T24 bladder cells showed increased IL-8 production after adenosine A 2B receptor activation [7] .
Conclusions
This study shows that the adenosine A 2B receptor is highly expressed in the uroepithelium and signals through the cAMP-CREB pathway. No evidence for a role of the adenosine A 2B receptor in the regulation of the host uroepithelial response was found. Activation of the low-expression adenosine A 2A receptor caused inhibition of ERK 1/2 and STAT3 phosphorylation, but it did not functionally affect UPEC-evoked IL-8 production.
